Key Highlights
- Kate Rollins joins as Chief Clinical Officer (CCO) to scale clinical operations.
- Josh Willeford appointed as Chief Financial Officer (CFO) to manage capital efficiency.
- Positive Development focuses on expanding its developmental therapy services nationwide.
- Rollins and Willeford bring extensive healthcare and financial leadership experience.
- Commitment to evidence-based developmental care for neurodivergent children and families.
Source: Business Wire
Notable Quotes
- “Kate is a fantastic addition to our senior executive team. Her leadership experience will greatly benefit our clinicians, colleagues, and clients at Positive Development.” — Mike Suiters, Co-founder and CEO at Positive Development
- “As a clinical strategy and operations leader with extensive knowledge on population health and care/utilization management, my background couldn’t have prepared me better for this role with Positive Development.” — Kate Rollins, CCO at Positive Development
- “I’ll be focused on furthering our mission in support of delivering quality, evidence-based Developmental Care to all families in need.” — Josh Willeford, CFO at Positive Development
SoHC's Take
The strategic appointments of Kate Rollins and Josh Willeford underscore Positive Development’s commitment to expanding its high-quality developmental care services nationwide. Rollins’ extensive clinical leadership experience, combined with Willeford’s financial acumen, positions the company for significant growth and enhanced service delivery. This leadership reinforcement not only aims to broaden access to their transformative developmental care but also solidifies their dedication to evidence-based practices and operational excellence. As the demand for developmental therapy for children on the autism spectrum continues to rise, Positive Development’s strengthened executive team is poised to make a substantial impact on the lives of neurodivergent children and their families across the country.
